Lactobacillus salivarius is a naturally occurring bacterium found in the mouth, intestines, and other mucosal surfaces, and it has drawn attention for its versatile probiotic properties. Research suggests it may support oral and dental health by competing with harmful bacteria linked to cavities and gum disease, while studies indicate it also shows promise in helping manage eczema symptoms and supporting balanced immune responses. Its potential role in gut health has been explored in research examining its ability to reinforce the intestinal barrier and modulate inflammation, and some clinical studies have investigated its capacity to inhibit Helicobacter pylori, the bacterium associated with stomach ulcers. Commonly available in probiotic capsule form, L. salivarius remains an active area of scientific inquiry with a growing body of supportive, though still evolving, evidence.
Compare this supplementResearch suggests that Lactobacillus salivarius may support immune function through several mechanisms, including mod...
View studies →Research suggests that Lactobacillus salivarius may support gut health across several animal models, with studies in ...
View studies →Research suggests that higher levels of Lactobacillus salivarius in saliva may be associated with better resistance t...
View studies →The studies provided do not contain research on Lactobacillus salivarius or its use in relation to H. pylori support....
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 99,999,999.99 CFU | Daily | eczema relief in infants and children | Based on RCTs examining L. salivarius LS01 and similar strains for atopic dermatitis |
| Capsule | 99,999,999.99 CFU | Daily | gut health and general immune function | Common in clinical trials using L. salivarius strains for GI and immune outcomes |
| Capsule | 99,999,999.99 CFU | Twice daily | H. pylori support as adjunct to standard therapy | Used in clinical trials as adjunct probiotic alongside antibiotic eradication regimens |
| Powder | 99,999,999.99 CFU | Daily | infant and pediatric gut health and immune function | Common dose form used in pediatric RCTs for early-life probiotic supplementation |
| Tablet | 99,999,999.99 CFU | Twice daily | dental and oral health including reduction of oral pathogens | Based on clinical studies using oral probiotic lozenges or tablets with L. salivarius |